Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Ranitidine Products Recalled Because of N-nitrosodimethylamine Contamination
WASHINGTON, D.C. — Stakeholders for the U.S. Food and Drug Administration (FDA) recalled the popular over-the-counter acid reflux medication Zantac recently because of the threat that the drug contains dangerously high levels of the suspected human carcinogen identified as N-nitrosodimethylamine (NDMA). The generic label for the … [Read more...] about Ranitidine Products Recalled Because of N-nitrosodimethylamine Contamination
FDA Says that Drug Makers Must Stop Ranitidine Sales
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) told drug makers who sell ranitidine-based medications to stop. Ranitidine is the generic name for the active ingredient in acid-reducing drugs like Zantac. Zantac is known as the most-prescribed drug across the globe in 1987, according to Wired. Now the FDA has asked … [Read more...] about FDA Says that Drug Makers Must Stop Ranitidine Sales
Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Another Ranitidine Recall Announced by the FDA
WASHINGTON, D.C. — American Health Packaging announced a voluntary recall of ranitidine tablets, USP150 mg, in 100-count blister packs after finding a potential human carcinogen in the medication. According to an announcement published by the U.S. Food and Drug Administration (FDA), American Health Packaging said that the recall is … [Read more...] about Another Ranitidine Recall Announced by the FDA
Another Ranitidine Product Recalled
BRIDGEWATER, New Jersey — Amneal Pharmaceuticals, LLC, from Bridgewater, New Jersey announced that the company would recall several lots of its Ranitidine products because of N-Nitrosodimethylamine (NDMA) impurities found in its products. Scientists have identified NDMA as a potential carcinogen. NDMA exists in much of the food … [Read more...] about Another Ranitidine Product Recalled
Zantac Still Being Sold in US
USA- dailymail.co.uk writes that while other countries are removing Zantac from their drug stores, the heartburn medication can still be found in pharmacies in the United States. In Europe, four prescription varieties of the drug were subject to recalls. The generic variety, as well as the brand name versions of the drug, were found … [Read more...] about Zantac Still Being Sold in US
Walmart, Rite Aid, and Walgreens Recall Ranitidine
MIAMI, Fla. — Three major pharmaceutical retailers have recalled medications containing Ranitidine because of the presence of excessive amounts of the potential carcinogen NDMA. The Miami Herald reported that this latest recall is the second recall in one week of a drug containing NDMA in levels that exceed the U.S. Food and Drug … [Read more...] about Walmart, Rite Aid, and Walgreens Recall Ranitidine
FDA Warns of Carcinogen Lurking in Zantac
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) released a statement discussing the potential dangers users of ranitidine medications face. Ranitidine, the generic version of the anti-heartburn medication Zantac, may contain a potentially carcinogenic chemical according to the latest statement announced by the FDA. The … [Read more...] about FDA Warns of Carcinogen Lurking in Zantac
